Skip to main content
BC Innovations
Feature Story

Europe waking to the American dream

2015 numbers suggest Europe's getting better at commercializing academic science

By Mark Zipkin, Staff Writer

While Europe didn't see the spike in seed and series A financing that the U.S. biotech sector enjoyed in 2014, there are signs the region is beginning to capitalize on the strength of its academic science. But it's still too soon to know if this is a knock-on effect of the market Stateside or if this marks the maturing of a bona fide biotech ecosystem.

Last year's numbers show a handful of countries are leading the way, with U.K. companies receiving more than $280 million in seed and series A financing, and Switzerland and France receiving $104 million and $75 million, respectively. Germany - arguably an academic powerhouse - trailed with only $34 million. (See Figure: Seed and series A by country in Europe)

Read Article

Today's Biotech & Pharma News

  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial

Management Updates

There were no items published for this section in the most recent issue. Click more >> to read previously published items.

Preclinical Results

There were no items published for this section in the most recent issue. Click more >> to read previously published items.